TADALAFIL

101027 reported adverse events

Drug classes: Phosphodiesterase 5 Inhibitor [EPC]

These side effects are most commonly reported by patients taking TADALAFIL:

# Side effect Count
0 DYSPNOEA 12171
1 HEADACHE 11213
2 DIARRHOEA 8190
3 NAUSEA 6829
4 FATIGUE 6241
5 DEATH 6067
6 DRUG INEFFECTIVE 5626
7 DIZZINESS 5452
8 COUGH 4578
9 PNEUMONIA 4360
See all common reactions for TADALAFIL

TADALAFIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 125 0.6983
1 MALIGNANT MELANOMA STAGE II 75 0.4573
2 MALIGNANT MELANOMA STAGE I 97 0.3566
3 DEVICE WIRELESS COMMUNICATION ISSUE 77 0.2973
4 MALIGNANT MELANOMA STAGE III 60 0.2956
5 CATHETER SITE VESICLES 56 0.2872
6 CATHETER SITE PRURITUS 248 0.2825
7 CATHETER SITE RASH 118 0.2611
8 CATHETER MANAGEMENT 232 0.2581
9 DEVICE MAINTENANCE ISSUE 151 0.2568
See all enriched reactions for TADALAFIL